Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 313 Records) |
| Query Trace: Disease and FLT3[original query] |
|---|
| Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients. Molecular biology reports 2023 8 . Ayad M Ali, Gaza F Sal |
| Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. medRxiv : the preprint server for health sciences 2023 8 . Gege Gui, Laura W Dillon, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery Auletta, Firas El Chaer, Evan Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Stephen R Spellman, Scott L Zeger, Kristin M Page, Christopher S Hourig |
| Outcomes of Patients with FLT3 Positive Acute Myeloid Leukaemia; an Experience from a Tertiary Care Hospital in Karachi, Pakistan. Journal of cancer & allied specialties 2023 8 9 (2): 553. Maria Zulfiqar, Natasha Ali, Usman Shaikh, Hamzah Jehanzeb, Salman Arif, Zurrya Fasih Khan, Nabiha Saeed, Zeeshan Ans |
| Characteristics of molecular genetic mutations and their correlation with prognosis in adolescent and adult patients with ALL. Oncology 2023 7 . Xue Sun, Xiaoqian Liu, Ying Li, Xue Shi, Yahan Li, Ran Tan, Yujie Jiang, Xiaohui Sui, Xueling Ge, Hongzhi Xu, Xin Wang, Xiaosheng Fa |
| The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next-generation sequencing in adult acute myeloid leukemia patients with the FLT3-ITD mutation. Hematological oncology 2023 6 . Feifei Tang, Xiaosu Zhao, Guorui Ruan, Qian Jiang, Hao Jiang, Lanping Xu, Yu Wang, Xiaohui Zhang, Kaiyan Liu, Xiaojun Hua |
| Cytogenetically Normal Acute Myeloid Leukaemia at a Single Centre in South Africa. Hematology/oncology and stem cell therapy 2023 6 16 (4): 397-406. Nicholas Jenkins, Lee-Ann Blanshard, Marian Stone, Estelle Verburgh, Jenna Oosthuizen, Karen Shir |
| [Clinical study of induction chemotherapy followed by allogeneic hematopoietic stem cell transplantation in the treatment of FLT3-ITD(+) acute myeloid leukemia with normal karyotype]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 6 44 (3): 230-235. F Li, Y P Liu, H Zhu, M Hong, S X Qian, Y Zhu, W Y Shen, L J Chen, G S He, H X Wu, H Lu, J Y Li, K R Mi |
| Phase 1/2 Study of Sorafenib Added to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone in Untreated AML. Blood advances 2023 6 . Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival, Ryan D Cassaday, Vivian G Oehler, Pamela S Becker, Jacob Appelbaum, Janis L Abkowitz, Johnnie J Orozco, Sioban B Keel, Paul Hendrie, Bart L Scott, Cristina Maria M Ghiuzeli, Elihu Estey, Roland B Walt |
| How ITD Insertion Sites Orchestrate the Biology and Disease of FLT3-ITD-Mutated Acute Myeloid Leukemia. Cancers 2023 6 15 (11): . Tobias R Haage, Burkhart Schraven, Dimitrios Mougiakakos, Thomas Fisch |
| UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome. Blood cancer journal 2023 5 13 (1): 88. Julia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt, Sven Zukunft, Marita Hartwig, Christoph Röllig, Jan Moritz Middeke, Uta Oelschlägel, Utz Krug, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Mathias Hänel, Richard Noppeney, Ulrich Kaiser, Claudia D Baldus, Martin Kaufmann, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E Berdel, Hubert Serve, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Frank Kroschinsky, Christian Thiede, |
| Frequency and Prognostic Impact of Aberrant Antigens Expression among Egyptian Adult Acute Leukemia. Asian Pacific journal of cancer prevention : APJCP 2023 12 24 (12): 4301-4307. Omnia Kaheled, Salah Aref, Nadia El Menshawy, Mohamed Aref, Mohamed Ay |
| The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current oncology (Toronto, Ont.) 2023 12 30 (12): 10410-10436. Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne Mahe, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Sch |
| Rare variant associations with plasma protein levels in the UK Biobank. Nature 2023 10 622 (7982): 339-347. Ryan S Dhindsa, Oliver S Burren, Benjamin B Sun, Bram P Prins, Dorota Matelska, Eleanor Wheeler, Jonathan Mitchell, Erin Oerton, Ventzislava A Hristova, Katherine R Smith, Keren Carss, Sebastian Wasilewski, Andrew R Harper, Dirk S Paul, Margarete A Fabre, Heiko Runz, Coralie Viollet, Benjamin Challis, Adam Platt, , Dimitrios Vitsios, Euan A Ashley, Christopher D Whelan, Menelas N Pangalos, Quanli Wang, Slavé Petrovs |
| Measurable Residual Disease Monitoring in AML With FLT3-ITD Treated With Intensive Chemotherapy Plus Midostaurin. Blood advances 2024 9 . Frank G Rücker, Lars Bullinger, Sibylle Cocciardi, Sabrina Skambraks, Tamara J Luck, Daniela Weber, Julia Krzykalla, Ema Pozek, Isabelle Janina Schneider, Andrea Corbacioglu, Verena I Gaidzik, Annika Meid, Sophia Aicher, Frank Stegelmann, Anika Schrade, Frauke Theis, Walter Fiedler, Helmut R Salih, Gerald G Wulf, Hans J Salwender, Thomas Schroeder, Katharina S Götze, Michael W M Kühn, Michael Lübbert, Richard F Schlenk, Axel Benner, Felicitas R Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhn |
| Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a?<?3log reduction of MRD2 predicted poor survival. Annals of hematology 2024 9 . Wenbing Duan, Jinsong Jia, Jing Wang, Xiaohong Liu, Wenjing Yu, Xiaolu Zhu, Ting Zhao, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Hongxia Shi, Yingjun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jia |
| Description of lymphocyte and cytokine profiles in individuals with acute myeloid leukemia associated with FLT3-ITD and NPM1 mutation status. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2024 6 . Rogério Reis, Gabriel S Müller, Mariane M Santos, Allan S Santos, Herbert Santos, Lorene S Santos, Bruno A Lopes, Soraya C Trindade, Roberto J Meyer, Songelí M Frei |
| FLT3-TKD Measurable Residual Disease Detection Using Droplet Digital PCR and Clinical Applications in Acute Myeloid Leukemia. International journal of molecular sciences 2024 6 25 (11): . Eric Wenlong Li, Ngoc Yen Kim Tran, Derek McCulloch, Michael Krigstein, Alberto Catalano, Jad Othman, Edward Abadir, Cheryl Smith, Harry Ila |
| Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML. Blood 2024 5 . Jad Othman, Nicola Potter, Adam Ivey, Yanis Tazi, Elli Papaemmanuil, Jelena Jovanovic, Sylvie D Freeman, Amanda Frances Gilkes, Rosemary E Gale, Tanya Rapoz-D'Silva, Manohursingh Runglall, Michelle Kleeman, Pawan Dhami, Ian Thomas, Sean Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Kenneth Burnett, Charlotte S Wilhelm-Benartzi, Brian Jp Huntly, Nigel H Russell, Richard James Dill |
| Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia. Bone marrow transplantation 2024 11 . Gege Gui, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery J Auletta, Firas El Chaer, Evan C Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil G Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Wael Saber, Stephen R Spellman, Scott L Zeger, Kristin M Page, Laura W Dillon, Christopher S Hourig |
| FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML. Annals of hematology 2024 11 . Toshihiro Matsukawa, Masahiro Onozawa, Takeshi Kondo, Minoru Kanaya, Daisuke Hidaka, Shuichi Ota, Akio Mori, Akio Shigematsu, Takuto Miyagishima, Yasutaka Kakinoki, Junichi Hashiguchi, Satoshi Yamamoto, Masayo Yamamoto, Kentaro Wakasa, Mutsumi Takahata, Toshimichi Ishihara, Yoshihito Haseyama, Akihito Fujimi, Tetsuya Igarashi, Takehiro Sarashina, Satoshi Iyama, Ryoji Kobayashi, Hajime Sakai, Katsuya Fujimoto, Junki Inamura, Yuji Kanisawa, Shinsuke Hirabayashi, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshi |
| Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multi-center Cohort Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 11 . Guopan Yu, Yu Zhang, Sijian Yu, Zhao Yin, Guangyang Weng, Na Xu, Xin Du, Dongjun Lin, Jie Xiao, Zhiqiang Sun, Hongyu Zhang, Xinquan Liang, Ziwen Guo, Weihua Zhao, Min Dai, Zhiping Fan, Li Xuan, Hui Liu, Dan Xu, Jieyu Ye, Xuejie Jiang, Pengcheng Shi, Hua Jin, Qifa L |
| Characteristics and Prognosis of "Acute Promyelocytic Leukemia-like" Nucleophosmin-1-Mutated Acute Myeloid Leukemia in a Retrospective Patient Cohort. Biomedicines 2024 10 12 (10): . Vasiliki Papadopoulou, Giulia Schiavini, Gregoire Stalder, Valentin Basset, Jacqueline Schoumans, Mitja Nabergoj, Muriel Schall |
| [Pathogenesis and treatment of acute myeloid leukemia with FLT3 mutations]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2024 10 65 (9): 945-953. Yuichi Ishika |
| Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia. Blood advances 2024 10 . Romane Joudinaud, Augustin Boudry, Laurène Fenwarth, Sandrine Geffroy, Mikaël Salson, Hervé Dombret, Celine Berthon, Arnaud Pigneux, Delphine Lebon, Pierre Peterlin, Simon Bouzy, Pascale Flandrin-Gresta, Emmanuelle Tavernier, Martin Carre, Sylvie Tondeur, Lamya Haddaoui, Raphaël A Itzykson, Sarah Bertoli, Audrey Bidet, Eric Delabesse, Mathilde Hunault, Christan Récher, Claude Preudhomme, Nicolas Duployez, Pierre-Yves Dum |
| Flow cytometric measurable residual disease in adult acute myeloid leukemia: a preliminary report from Eastern India. Journal of hematopathology 2024 1 16 (1): 17-25. Neha Singh, Avinash Gupta, Sujeet Kumar, Gojiri Mawalankar, Bhumika Gupta, Nilesh Dhole, RohitKumar Kori, Anil Sin |
| Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. American journal of hematology 2024 1 . Nour Moukalled, Myriam Labopin, Jurjen Versluis, Gérard Socié, Didier Blaise, Urpu Salmenniemi, Alessandro Rambaldi, Tobias Gedde-Dahl, Eleni Tholouli, Nicolaus Kröger, Jean-Henri Bourhis, Peter Von Dem Borne, Etienne Daguindau, Edouard Forcade, Arnon Nagler, Jordi Esteve, Fabio Ciceri, Ali Bazarbachi, Mohamad Moh |
| Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 1 JCO2300943. Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dillon, Steven Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, |
| A germline FLT3 variant in aplastic anemia. Biomarker research 2025 1 13 (1): 4. Lemchukwu C Amaeshi, Amalia A Sofianidi, Aditi Shastri, Mendel Goldfinger, Marina Konopleva, Amit K Verma, Mark Chaitowitz, Ioannis Mantzar |
| Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with NPM1-mutated AML. HemaSphere 2025 1 9 (1): e70060. Sibylle Cocciardi, Maral Saadati, Nina Weiß, Daniela Späth, Silke Kapp-Schwoerer, Isabelle Schneider, Annika Meid, Verena I Gaidzik, Sabrina Skambraks, Walter Fiedler, Michael W M Kühn, Ulrich Germing, Karin T Mayer, Michael Lübbert, Elli Papaemmanuil, Felicitas Thol, Michael Heuser, Arnold Ganser, Lars Bullinger, Axel Benner, Hartmut Döhner, Konstanze Döhn |
| Evaluation of the Toxicity and Outcomes of the Combination of Midostaurin and CLAG-M in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML): A Multicenter Retrospective Analysis. The Annals of pharmacotherapy 2025 1 10600280241305608. Ashley Chen, Grace Baek, Kathryn Russell, Carole Shaw, Megan Othus, Jonathan Cohen, Shannon Palmer, Jack Rasmussen, Joseph Bubalo, Tenzin Tsomo, Tenley Schwarz, Swathi Namburi, Anna Halpe |
- Page last reviewed:Feb 1, 2024
- Content source: